AKT1 and B-cell chronic lymphocytic leukemia: If a similar pathway is active in CLL, it could explain the observed structural changes, as enhanced PI3K/AKT signaling is known to suppress the transcription factor FOXC1, a key regulator of adipocyte integrity.